Pemetrexed combined with Oxaliplatin or carboplatin as first-line treatment in advanced non–small cell lung cancer: a multicenter, randomized, phase II trial

GV Scagliotti, C Kortsik, GG Dark, A Price… - Clinical cancer …, 2005 - AACR
Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non–small cell lung cancer …
被引用次数：237 相关文章

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial

GV Scagliotti, C Kortsik, G Dark, A Price… - CLINICAL CANCER …, 2005 - iris.unito.it
PURPOSE: To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non-small cell lung cancer …
[PDF] academia.edu

[PDF][PDF] Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II …

GV Scagliotti, C Kortsik, GG Dark, A Price, C Manegold… - academia.edu
Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non–small cell lung cancer …

[引用][C] Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trial

GV Scagliotti, C Kortsik, GG Dark… - Clinical Cancer …, 2005 - produccioncientifica.ucm.es
Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non-small cell lung cancer …

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.

GV Scagliotti, C Kortsik, GG Dark, A Price… - … Cancer Research: an …, 2005 - europepmc.org
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small
cell lung cancer: a multicenter, randomized, phase II trial. - Abstract - Europe PMC Sign in …

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial

GV Scagliotti, C Kortsik, GG Dark… - … : an official journal …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non-small cell lung cancer …

[引用][C] Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trial

GV SCAGLIOTTI, C KORTSIK… - Clinical cancer …, 2005 - pascal-francis.inist.fr
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small
cell lung cancer: A multicenter, randomized, phase II trial CNRS Inist Pascal-Francis CNRS …

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trial

GV Scagliotti, C Kortsik, GG Dark, A Price… - Clinical Cancer …, 2005 - eprints.ncl.ac.uk
Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in
chemonaive patients with locally advanced or metastatic non-small cell lung cancer …

[引用][C] Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trial

GV SCAGLIOTTI, C KORTSIK… - Clinical …, 2005 - American Association for Cancer …